Given the reliance of prostate cancer cells on this signal, nullification of AR activity is the first line of therapeutic intervention for disseminated disease, as achieved through either ligand depletion (androgen ablation strategies) or through the use of direct AR antagonists that prevent formation of active AR transcriptional complexes (Klotz 2000; Reid et al. 1999). Here, AR is linked to Familial prostate cancer.